Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic pharmaceutical formulations and branded products in India. The company provides tablets, capsules, injections, ophthalmic, liquid orals, softgel capsules, ointments, creams and gels, powder for injections, suppositories, ovules, pre-mix bag formulations, inhalers, and sprays and IV infusion. It also provides dry syrups, lyophilized vials, prefilled syringes, emulsion injection, and topicals. Caplin Point Laboratories Limited was incorporated in 1990 and is headquartered in Chennai, India.

Revenue projections:

Revenue projections for CAPLIPOINT
Revenue projections for CAPLIPOINT

CAPLIPOINT's projected revenue decline from last year is likely to make investors cautious. Lower revenues often hurt a company's bottom line, leading investors to be concerned about the company's ability to maintain profitability and deliver strong financial results in the future.

Financial Ratios:

currentRatio 6.965000
forwardPE 21.565434
debtToEquity 0.174000
earningsGrowth 0.175000
revenueGrowth 0.104000
grossMargins 0.602140
operatingMargins 0.300570
trailingEps 70.280000
forwardEps 0.000000

CAPLIPOINT's current ratio of 6.965 shows that the company has ample resources to service its short-term debt. This indicates a solid financial position, as CAPLIPOINT can rely on its cash reserves and current assets to cover its immediate liabilities without strain.
CAPLIPOINT's Forward PE is in an attractive range, meaning its stock price aligns well with earnings and isn't inflated. This creates room for growth, making it a solid investment opportunity for those looking to benefit from potential price appreciation.
Caplin Point Laboratories Limited's positive earnings and revenue growth signal that the company is expected to expand its business. The company's increasing profits and sales reflect strong financial health, suggesting continued growth and success in the coming periods.
CAPLIPOINT's positive gross and operating margins suggest that the company is operating profitably. These strong margins indicate effective cost management and revenue generation, contributing to a solid financial foundation.

Price projections:

Price projections for CAPLIPOINT
Price projections for CAPLIPOINT



Recommendation changes over time:

Recommendations trend for CAPLIPOINT
Recommendations trend for CAPLIPOINT


A recent buy bias from analysts toward CAPLIPOINT may inspire confidence in investors, who could view the stock as a promising investment. This positive sentiment suggests that CAPLIPOINT might be an appealing option for those looking to grow their wealth through stock market investments.